Literature DB >> 19201137

Pneumoscrotum after jejunal perforation: a case report.

Travis W Hill1, Lisa D Mills, Christine J Butts.   

Abstract

BACKGROUND: Pneumoscrotum is a rare disease entity in which gas is present in the scrotum. It has been described after diagnostic and therapeutic procedures, as well as with disease states. The entity itself is a benign condition, but is associated with both incidental and life-threatening conditions.
OBJECTIVES: We discuss the pathophysiology and associated conditions of pneumoscrotum. CASE REPORT: We report a case of pneumoscrotum after jejunum perforation.
CONCLUSION: Even though pneumoscrotum is a benign, rare condition, its mere presence should signal the possibility of a severe, life-threatening disease process within the peritoneum or retroperitoneum. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Mesh:

Year:  2009        PMID: 19201137     DOI: 10.1016/j.jemermed.2008.09.023

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  4 in total

Review 1.  Critical Manifestations of Pneumoscrotum.

Authors:  Gautam Dagur; Min Y Lee; Kelly Warren; Reese Imhof; Sardar A Khan
Journal:  Curr Urol       Date:  2016-05-20

2.  Pneumoscrotum in patient with pneumothorax: A case report.

Authors:  Rama Firmanto; Fina Widia; Gampo Alam Irdam
Journal:  Urol Case Rep       Date:  2019-05-24

3.  Pneumoscrotum as complication of blunt thoracic trauma: a case report.

Authors:  Eftychios Lostoridis; Konstantinos Gkagkalidis; Nikolaos Varsamis; Nikolaos Salveridis; Georgios Karageorgiou; Spyridon Kampantais; Paraskevi Tourountzi; Konstantinos Pouggouras
Journal:  Case Rep Surg       Date:  2013-01-14

4.  Pneumoscrotum: report of two different cases and review of the literature.

Authors:  Giovanni Cochetti; Francesco Barillaro; Emanuele Cottini; Francesco D'Amico; Alberto Pansadoro; Solajd Pohja; Andrea Boni; Roberto Cirocchi; Veronica Grassi; Rosa Mancuso; Elisa Silvi; Katifenia Ioannidou; Maria Giulia Egidi; Giulia Poli; Ettore Mearini
Journal:  Ther Clin Risk Manag       Date:  2015-04-09       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.